It has been found to be overexpressed in a broad spectrum of tumors including lung cancer wherein higher plasma levels of IGFBP2 have been positively associated with tumor size, lymph node metastasis, advanced tumor stage, and shorter overall survival [37]. Here, IGFBP2 is linked to lung cancer.